Can oral contraceptive (birth control) pills cause decreased Dehydroepiandrosterone (DHEA) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Birth Control Pills Cause Low DHEA Levels?

Yes, oral contraceptive pills containing estrogen consistently decrease DHEA and DHEA-S (dehydroepiandrosterone sulfate) levels by approximately 20-60% compared to baseline. This effect is well-documented and occurs through suppression of adrenal androgen production.

Mechanism and Magnitude of Effect

The reduction in DHEA levels with combined oral contraceptives occurs through multiple pathways:

  • Estrogen-containing oral contraceptives reduce plasma DHEA, DHEA-S, and androstenedione levels by inhibiting delta5-pregnenolone synthesis from cholesterol, which is a precursor in the androgen synthesis pathway 1

  • The decrease in DHEA-S levels averages approximately 57% (from mean 2,062 ng/mL to 895 ng/mL) and likely results from reduced adrenocorticotropic hormone (ACTH) release, leading to decreased adrenal secretion 2

  • Treatment with a COC containing 30 mcg ethinylestradiol and 3 mg drospirenone reduces exposure to DHEA and DHEA-S by at least 20%, affecting both adrenal and ovarian androgen production 3

Dose-Dependent Effects

The magnitude of DHEA suppression varies with estrogen dose:

  • Higher estrogen doses (35 mcg ethinylestradiol) produce significantly greater reductions in DHEA-S (from 7.26 to 5.22 micromol/L, p<0.02) compared to lower doses (25 mcg), though both formulations reduce levels 4

  • The 35 mcg formulation also produces more pronounced decreases in total and free testosterone compared to 25 mcg formulations, suggesting a dose-response relationship for androgen suppression 4

Clinical Implications

While the biochemical effect is clear, the clinical significance remains debated:

  • Co-administration of 50 mg daily DHEA can fully compensate for the loss of adrenal androgens during COC use, restoring total testosterone levels to baseline 3

  • However, DHEA supplementation (50 mg) did not result in consistent improvements in sexual function, mood, or quality of life in women taking ethinylestradiol/drospirenone, suggesting this dose may be insufficient for complete normalization of free testosterone 5

  • Small improvements were noted in autonomic reactions and behavior scores with DHEA supplementation, but the clinical relevance of these changes is uncertain 5

Important Caveats

  • Progestin-only contraceptives do not appear to have the same suppressive effect on DHEA levels, as the mechanism is primarily estrogen-mediated 6

  • The reduction in DHEA levels is reversible upon discontinuation of estrogen-containing contraceptives, as the effect is functional rather than structural

  • Individual variability is substantial, with some women experiencing more pronounced suppression than others based on baseline adrenal function 4

Related Questions

In a 31-year-old woman on Yasmin (drospirenone/ethinyl estradiol) and spironolactone, why are total testosterone, free testosterone, estradiol, and progesterone all low, and what should be done to assess for underlying androgen excess or for fertility planning?
Does oral estrogen therapy affect mood and sexual desire?
Do mood effects associated with Yaz (drospirenone and ethinyl estradiol) resolve with time?
What are the differences between Ortho Tri‑Cyclen Lo (low‑dose ethinyl estradiol/norgestimate) and standard Ortho Tri‑Cyclen (regular‑dose ethinyl estradiol/norgestimate) regarding hormone content, side effects, and contraceptive efficacy?
A patient who has been on the combined oral contraceptive Junel (ethinyl estradiol 0.02 mg and norgestimate 0.25 mg) for 11 years and does not want to resume hormonal contraception now presents with hair loss, acne, mood swings, and decreased libido; what management recommendations are appropriate?
Is a patient's persistent hip pain after falling, unrelieved by trochanteric bursae (greater trochanter bursa) injections and initially attributed to arthritis, but significantly relieved by self-treatment with a vibrating ball on the ischiogluteal bursa, a case of misdiagnosis?
Can long-term use of birth control pills (oral contraceptives) cause low estradiol levels (hypogonadism)?
What is the most appropriate initial investigation for a patient presenting with a painless abdominal mass?
What causes a bitter taste in the mouth?
Should a patient be automatically treated for chlamydia and gonorrhea if their partner was diagnosed with chlamydia, or should they be tested first?
What is the next step in managing a patient with persistent sore throat and cervical lymph node swelling, who completed a round of antibiotics and tested negative for strep, with worsening symptoms and a swollen tonsil with a white patch?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.